bexarotene gel 1% — CareFirst (Caremark)
Sézary syndrome (SS)
Initial criteria
- Authorization may be granted for treatment of MF or SS.
Reauthorization criteria
- Authorization may be granted if no evidence of unacceptable toxicity or disease progression while on current regimen.
Approval duration
12 months